This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024
Secure Your Spot
Menu
BOOK NOW

Jordon Wang, Ph.D.
COO and SVP of Technology Development at AvantGen
Speaker

Profile

Dr. Jordon Wang is the Chief Operating Officer and Senior Vice President of Technology Development at AvantGen. The team is dedicated in accelerating antibody-based therapeutics for their scientific partners by using innovative platforms. Prior to joining AvantGen, Jordon served as VP of Technology Development and VP of Antibody Discovery at LakePharma, now part of Curia. He earned a B.S. in Biological Sciences and a Ph.D. in Cancer Biology at Stanford University.

Agenda Sessions

  • Development of a NK Cell Engager Utilizing Antibodies Targeting a Single Amino Acid Variation

    , 1:45pm
    View Session

At this event

Prev
Next
Jun Wang, Ph.D.
Assistant Professor, Department of Pathology
NYU Grossman School of Medicine

See Jordon at Antibody Engineering & Therapeutics US

Secure Your Spot